Holly P. Quach

Vitamin D Receptor Activation Down-regulates the Small Heterodimer Partner and Increases CYP7A1 to Lower Cholesterol

Edwin C.Y. Chow, Lilia Magomedova, Holly P. Quach et al. · Gastroenterology · 2013 · 85 citations

Metabolic Syndrome, Molecular Pharmacology, Increases Cyp7a1 +13

Temporal changes in tissue 1α,25-dihydroxyvitamin D₃, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)₂D₃treatment in mice

Edwin C.Y. Chow, Holly P. Quach, Reinhold Vieth et al. · American Journal of Physiology-Endocrinology and Metabolism · 2013 · 65 citations

Renal Trpv6 Expression, Parathyroid Gland, Molecular Pharmacology +19

Effects of 1α,25-Dihydroxyvitamin D 3 , the Natural Vitamin D Receptor Ligand, on the Pharmacokinetics of Cefdinir and Cefadroxil, Organic Anion Transporter Substrates, in Rat

Yu Chul Kim, In‐Bong Kim, Chi‐Kyoung Noh et al. · Journal of Pharmaceutical Sciences · 2014 · 29 citations

Biochemistry, Physiology, Experimental Pharmacology +2

Disrupted Murine Gut–to–Human Liver Signaling Alters Bile Acid Homeostasis in Humanized Mouse Liver Models

Edwin C.Y. Chow, Holly P. Quach, Yueping Zhang et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 25 citations

Low Levels of GSTA1 Expression Are Required for Caco-2 Cell Proliferation

Humaira Adnan, Holly P. Quach, Kimberley MacIntosh et al. · PLoS ONE · 2012 · 22 citations · Full text

Apoptosis, Immunology, Spontaneous Differentiation +18